N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide (Compound)

Description: A compound in the knowledge graph

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide's neighborhood in the knowledge graph.

Submit

Knowledge Graph Assertions

Source	Relation	Target	Evidence
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	NVL Gene (Entity type)	0.0053433566
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	C1QA Gene (Entity type)	0.0059353393
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Bioactivity Knowledge Graph Relation (Entity type)	Endothelin receptor type B Protein (Entity type)	IC50
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	Gliclazide Compound (Entity type)	0.7502368688583374
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	LTF Gene (Entity type)	0.005172531
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	In similarity relationship with Knowledge Graph Relation (Entity type)	amikacin Compound (Entity type)	0.7542025446891785
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	AMDHD2 Gene (Entity type)	0.004842073
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Positively regulates Knowledge Graph Relation (Entity type)	ACADVL Gene (Entity type)	0.0049952767
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	EIF5A Gene (Entity type)	-0.005460809
N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide Compound (Entity type)	Negatively regulates Knowledge Graph Relation (Entity type)	THBS1 Gene (Entity type)	-0.005713728

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
NVL
Gene (Entity type)
0.0053433566

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
C1QA
Gene (Entity type)
0.0059353393

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Bioactivity
Knowledge Graph Relation (Entity type)
Endothelin receptor type B
Protein (Entity type)
IC50

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
Gliclazide
Compound (Entity type)
0.7502368688583374

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
LTF
Gene (Entity type)
0.005172531

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
In similarity relationship with
Knowledge Graph Relation (Entity type)
amikacin
Compound (Entity type)
0.7542025446891785

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
AMDHD2
Gene (Entity type)
0.004842073

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Positively regulates
Knowledge Graph Relation (Entity type)
ACADVL
Gene (Entity type)
0.0049952767

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
EIF5A
Gene (Entity type)
-0.005460809

N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]-ethoxy]-4-pyrimidinyl]-N'-propylsulfamide
Compound (Entity type)
Negatively regulates
Knowledge Graph Relation (Entity type)
THBS1
Gene (Entity type)
-0.005713728

DISPLAY PER PAGE

Knowledge Graph Assertions

	Source	Relation	Target	Evidence
Loading results...

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.